Navigation Links
Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group
Date:3/16/2011

SHANGHAI, March 16, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.  Shenogen Pharma Group is a China-based drug development venture that develops innovative therapeutics for the treatment of oncology indications including breast cancer and leukemia.

"We have evaluated multiple potential antibody development service partners in China," said Dr. Xueming Qian, who joined Shenogen as Vice President of Biology and Antibody Technology last June after working for twelve years in Amgen's discovery research group at its Thousand Oaks, California site.  "We decided to work with ChemPartner's Biologics Services team because they have the required therapeutic antibody drug research and development experience, expertise and people to support our therapeutic antibody program."

ChemPartner will be responsible for a spectrum of drug discovery activities for an integrated antibody drug development program including target protein production and cell line development, lead antibody generation and optimization (humanization and affinity maturation), assay development, protein analytics, DMPK, and in vivo pharmacology.

Dr. Chengbin Wu, Vice President of Biologics Services of ChemPartner, added, "We are delighted that Shenogen, an innovative drug development company, chose ChemPartner as its preferred outsource partner for antibody drug development.  Shenogen has a world-class management team and exclusive global intellectual property rights on a novel targ
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
2. American Scientific Resources Inc. Opens Shanghai Location
3. Shanghai ChemPartner Is Pleased to be Part of Agios Groundbreaking Cancer Research
4. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
5. China-Biotics to Host Investor Day in Shanghai to Discuss Corporate Development Strategy
6. Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification
7. Special Event Providing Exclusive Access to Shanghais Booming Zhangjiang Pharma Valley Added to Agenda of First Annual SBS China Conference
8. Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai
9. NSF International Opens NSF Shanghai Testing Laboratory in China to Support Increasing Demand for Testing and Certification Services
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015  Delcath Systems, Inc. (NASDAQ: DCTH ... focused on oncology with an emphasis on the ... the reporting of data from a single -center ... with the Delcath Hepatic Delivery System (Melphalan/HDS) and ... Society of Surgical Oncology (SSO) Annual Meeting 2015.  ...
(Date:3/27/2015)... , March 27, 2015  WebMD Health ... source of health information, today announced an ... National Action Plan for Combating Antibiotic-Resistant ... emphasized the urgency and importance of addressing ... and global health.    The WebMD ...
(Date:3/26/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... therapies for cardiovascular disease and overall health, announced that ... of the Corporation (the "Common Shares"). The Common Shares ... 5 th , 2014 to March 4 th , ... on or before April 1, 2015. Interest on the ...
Breaking Medicine Technology:Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
(Date:3/27/2015)... When struck with the aftermath of ... where to begin. The latest eBook released by ... offers accident victims a clear and concise process for ... their personal injury claim is seen through to successful ... actions that should be taken immediately following the trucking ...
(Date:3/27/2015)... 2015 Trail mix is the perfect, healthy ... weekend hikes and during the game! It’s portable, lightweight and ... proud to introduce a new line of specialty trail mixes ... and flavorful selections packed with nutritious, 100% all natural ingredients. ... grains that add protein and fiber to your diet and ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Approximately ... for Healthy Kids Coalition Lobby Day to lobby ... Health Improvement Program (SHIP). Everlast Climbing was ... PE Bill SF343/HF498 which would strengthen physical education ... student assessments and other measures to strengthen physical ...
(Date:3/27/2015)... 27, 2015 Since September 2014, the country ... comeback tour after having been in retirement for a period ... the performer to return to touring, and concert events have ... Omaha will likely sell out for the two shows recently ... to view the inventory of discounted Garth Brooks tickets ...
(Date:3/27/2015)... Canadian Cannabis Clinics ( http://www.cannabisclinics.ca ... utilization of medical cannabis as a treatment for ... and clinics dedicated to providing access to safe ... for patients searching for medical marijuana treatment in ... their sub domain for Canada. , With ...
Breaking Medicine News(10 mins):Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Canadian Cannabis Clinics (CCC) to Join the Canada.MarijuanaDoctors.com Network 2
... for regulating the immune system, an international team of ... that have the potential to treat diseases involving inflammation, ... The team started by creating a three-dimensional map of ... on the surface of human cells and plays a ...
... HealthDay Reporter , MONDAY, May 14 (HealthDay News) -- ... may help relieve shortness of breath during activity, Japanese ... that makes it hard to breathe; it is commonly ... "The effects of acupuncture are large," said Dr. George ...
... , SUNDAY, May 13 (HealthDay News) -- A new type ... people who have lost their vision due to degenerative eye ... research with rats. The system uses tiny solar panel-like ... a specially designed pair of goggles equipped with a miniature ...
... study has found that, contrary to current thinking, taking beta ... person,s risk of developing colorectal cancer. Published early online in ... Society, the study also revealed that even long-term use or ... risk. In recent years, researchers have thought that beta ...
... May 10 (HealthDay News) -- An advisory panel to the ... the weight-loss medication lorcaserin, even though concerns remain about cardiovascular ... nod to the drug, lorcaserin would become the first new ... FDA is not bound to follow the advice of its ...
... cause of death among children under 5, according to a ... School of Public Health. They examined the distribution of child ... percent were attributable to infectious causes and 40 percent occurred ... of the Lancet , suggest a decline in the ...
Cached Medicine News:Health News:Novel drug candidates offer new route to controlling inflammation 2Health News:Novel drug candidates offer new route to controlling inflammation 3Health News:Acupuncture May Help Ease Symptoms of COPD 2Health News:Acupuncture May Help Ease Symptoms of COPD 3Health News:In Rat Study, Eye Device Shows Promise for Restoring Sight 2Health News:Blood pressure drugs don't protect against colorectal cancer 2Health News:FDA Panel Gives Blessing to New Weight-Loss Drug 2Health News:Pneumonia and preterm birth complications are the leading causes of childhood death 2
Inquire...
Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
... BD Vacutainer® SST™ ... and a polymer gel ... are used for serum ... also provide an efficient ...
Medicine Products: